Piermont Capital Management’s Imperva, Inc. IMPV Stock Holding History

Piermont Capital Management’s Portfolio IMPV Stock Details IMPV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,510	Closed	-$362K	–	255
2018 Q2	$362K	Buy	+7,510	New	+$359K	0.11%	195

Other funds holding IMPV

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Piermont Capital Management's IMPV Position: Q3 2018 in Review

Piermont Capital Management sold out of Imperva, Inc. (IMPV) in Q3 2018, closing a stake of 7,510 shares — an estimated $362K sold.

Piermont Capital Management first reported a position in IMPV in Q2 2018 and held it in 1 quarter. The position peaked at $362K in Q2 2018. 168 funds tracked by Wall St. Rank hold IMPV as of Q3 2018.

Piermont Capital Management reported no remaining Imperva, Inc. position as of Q3 2018 after selling out during the quarter.
Piermont Capital Management sold 7,510 Imperva, Inc. shares in Q3 2018, an estimated $362K.
Piermont Capital Management first reported a position in Imperva, Inc. in Q2 2018 and held it in 1 quarter.
Piermont Capital Management's Imperva, Inc. position peaked at $362K in Q2 2018.
168 funds tracked by Wall St. Rank held Imperva, Inc. as of Q3 2018.

Based on Piermont Capital Management's 13F filing for Q3 2018, filed 6 Nov 2018.